We should emphasize the role of international organizations in the development of HTA in Hungary. As an outstanding achievement of local efforts and international support (a World Bank loan), a Health Services Management Training Center at the Semmelweis University in Budapest and a School of Public Health at the University of Debrecen was established in the middle of 1990s, both serving as an important academic institution for healthcare policy makers and hospital managers not only in Hungary but also in Central and Eastern Europe. The Health Evidence Network (HEN) of the World Health Organization (WHO) had also significant effect on the development of Hungarian HTA.
Another important milestone of HTA development in Hungary was the inclusion of HTA into the governmental decision-making process of pharmaceutical reimbursement after 1 May 2004, when Hungary joined to European Union. Although submission of an HTA report is not compulsory in Hungary in course of application for health insurance reimbursement, a health technology assessment report can provide valuable information for health insurance decision makers and can strengthen the application dossier.
The current research topics in Hungary-in line with the international literature (17;18;23;26)-covers, for example, osteoporosis and arthritis (14-16;27;28) , oncology and cancer screening (4;5;9-13;25), healthcare financing (1;6-8), and coverage policy (19;20;22) . In addition to the universities and research centers, the Hungarian National Health Insurance Fund Administration (Országos Egészségbiztosítási Pénztár, OEP) played an active role in the publication of scientific papers in the field of HTA.
Finally, we would like to highlight the important role of Professors Egon Jonsson and David Banta in the worldwide development of HTA in the past decades, with special respect to their commitment to the introduction, development, and permeation of HTA in Hungary.
